DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United Kingdom
  • /
  • Food, Beverage & Tobacco
Author Program NEWCreate Narrative
TATE logo

Tate & Lyle plc Stock Price

LSE:TATE Community·UK£2.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 61 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

TATE Share Price Performance

UK£0
-5.18 (-100.00%)
​
UK£5.35
Fair Value
UK£0
-5.18 (-100.00%)
​
Price UK£0
Wed, 15 Jul 26
Fair ValueUK£5.35
Share Pricen/a

TATE Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value UK£5.35 4.3% overvalued intrinsic discount

TATE: Revenue Guidance Revisions Will Drive Near-Term Re-Rating Opportunity

3users have liked this narrative
0users have commented on this narrative
35users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value UK£4.14 34.9% overvalued intrinsic discount

Regulatory And Integration Hurdles Will Constrain Upside But Spur Revaluation

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value UK£6.15 9.3% undervalued intrinsic discount

Rising Health Trends And Urbanization Will Expand Specialty Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
TATE logo
Tate & Lyle
34.9% overvalued intrinsic discount

Regulatory And Integration Hurdles Will Constrain Upside But Spur Revaluation

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 30 Jul
Read Narrative
TATE logo
Tate & Lyle
4.3% overvalued intrinsic discount

TATE: Revenue Guidance Revisions Will Drive Near-Term Re-Rating Opportunity

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 15 Jul
Read Narrative
TATE logo
Tate & Lyle
9.3% undervalued intrinsic discount

Rising Health Trends And Urbanization Will Expand Specialty Markets

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 1 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
TATE logo

TATE: Future Share Price Will Reflect Risks Around Ingredion Takeover Proposal

Fair Value: UK£4.14 34.9% overvalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
TATE logo

TATE: Ingredion Offer And Margin Delivery Will Shape Balanced Future Returns

Fair Value: UK£5.35 4.3% overvalued intrinsic discount
35 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
TATE logo

TATE: Ingredion Offer And Margin Outlook Will Shape Balanced Future Return Potential

Fair Value: UK£6.15 9.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Proven track record with low risk.

3 Risks
3 Rewards
View Full Analysis

Tate & Lyle plc Key Details

UK£2.0b

Revenue

UK£1.1b

Cost of Revenue

UK£919.0m

Gross Profit

UK£822.0m

Other Expenses

UK£97.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Nov 05, 2026
0.22
45.81%
4.84%
77.5%
View Full Analysis

About TATE

Founded
1903
Employees
4840
CEO
Anthony Nicholas Hampton
WebsiteView website
www.tateandlyle.com

Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company’s products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications. The company has a strategic collaboration with BioHarvest Sciences Inc. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.

Recent TATE News & Updates

User avatar
Narrative Update • Jul 30

TATE: Future Share Price Will Reflect Risks Around Ingredion Takeover Proposal

Analysts have modestly raised their fair value estimate for Tate & Lyle, with the implied price target moving from about £3.75 to roughly £4.14. This reflects updated assumptions on revenue growth, profit margin and future P/E, even as recent research has shifted ratings toward Hold.
User avatar
Narrative Update • Jul 15

TATE: Ingredion Offer And Margin Delivery Will Shape Balanced Future Returns

Tate & Lyle’s updated analyst work points to a modestly higher fair value estimate, with the aggregate price target now effectively aligned around the mid £5 range. Analysts reflect a slightly higher discount rate, a small adjustment to revenue and margin assumptions, and a higher future P/E, set against recent downgrades to Hold ratings linked to the Ingredion offer.

Recent updates

No updates

Tate & Lyle plc Competitors

CWK logo

Cranswick

Symbol: LSE:CWK
Market cap: UK£2.7b
GNC logo

Greencore Group

Symbol: LSE:GNC
Market cap: UK£2.0b
PFD logo

Premier Foods

Symbol: LSE:PFD
Market cap: UK£1.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide